Fadi Braiteh

536 total citations
19 papers, 389 citations indexed

About

Fadi Braiteh is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fadi Braiteh has authored 19 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fadi Braiteh's work include HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Fadi Braiteh is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Fadi Braiteh collaborates with scholars based in United States, Canada and Switzerland. Fadi Braiteh's co-authors include Razelle Kurzrock, Bita Esmaeli, Cynthia A. Boxrud, Éduardo Bruera, Sriram Yennurajalingam, Siyeon Park, Monika Parisi, Quanhong Ni, Claudio Faria and James L. Abbruzzese and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fadi Braiteh

19 papers receiving 375 citations

Peers

Countries citing papers authored by Fadi Braiteh

Since Specialization

Citations

This map shows the geographic impact of Fadi Braiteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Braiteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Braiteh more than expected).

Fields of papers citing papers by Fadi Braiteh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi Braiteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Braiteh. The network helps show where Fadi Braiteh may publish in the future.

Co-authorship network of co-authors of Fadi Braiteh

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Braiteh. A scholar is included among the top collaborators of Fadi Braiteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Braiteh. Fadi Braiteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Comparative effectiveness of early-line nab-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis 2018 ·SHILAP Revista de lepidopterología ·(unknown), Monika Parisi, Stefan Glück, (unknown), Sungha Park, Corey Pelletier, Claudio Faria, Fadi Braiteh	2
2	Comparative effectiveness of early-line <em>nab</em>-paclitaxel vs. paclitaxel in patients with metastatic breast cancer: a US community-based real-world analysis 2018 ·Cancer Management and Research ·Reshma Mahtani, Monika Parisi, Stefan Glück, Quanhong Ni, Siyeon Park, Corey Pelletier, Claudio Faria, Fadi Braiteh	23
3	Comparative effectiveness and resource utilization of <em>nab</em>-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting 2017 ·Cancer Management and Research ·Fadi Braiteh, Manish Patel, Monika Parisi, Quanhong Ni, Siyeon Park, Claudio Faria	31
4	Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with advanced cancers of the GI tract and anus. 2017 ·Journal of Clinical Oncology ·Alexa B. Schrock, Lauren Young, Samuel J. Klempner, Rodolfo Bordoni, Jeffrey S. Ross, Philip J. Stephens, Craig Devoe, Fadi Braiteh, Siraj M. Ali, Vincent A. Miller	2
5	A phase 2 study of napabucasin with weekly paclitaxel in previously treated metastatic breast cancer. 2017 ·Journal of Clinical Oncology ·William J. Edenfield, Carlos Becerra, Adrian Langleben, Alexander I. Spira, Fadi Braiteh, (unknown), Yuan Gao, Youzhi Li, Matthew Hitron, Chiang Li	3
6	A phase Ib/II study of BBI608 combined with weekly paclitaxel in advanced pancreatic cancer. 2016 ·Journal of Clinical Oncology ·Tanios Bekaii‐Saab, Sameh Mikhail, Adrian Langleben, Carlos Becerra, Derek J. Jonker, Timothy R. Asmis, Gregory M. Coté, Christina Wu, Eunice L. Kwak, Alexander I. Spira, Fadi Braiteh, Stephen Richey, Stephanie Hume, Matthew Hitron, Chiang Li	9
7	A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer. 2016 ·Journal of Clinical Oncology ·Carlos Becerra, Fadi Braiteh, Alexander I. Spira, Adrian Langleben, Lawrence Panasci, Svetislava J. Vukelja, (unknown), Rachel Goodwin, Timothy J. Panella, William J. Edenfield, (unknown), Stephanie Hume, Youzhi Li, Matthew Hitron, Chiang Li	9
8	A phase Ib/II study of cancer stemness inhibitor napabucasin (BB608) combined with weekly paclitaxel in platinum-resistant ovarian cancer. 2016 ·Journal of Clinical Oncology ·Agustin A. García, John L. Hays, Gregory M. Coté, Carlos Becerra, Adrian Langleben, Susie Lau, Lynda D. Roman, Colleen McCormick, Donald Richards, Fadi Braiteh, Habte Yimer, Stephen Richey, William J. Edenfield, (unknown), Stephanie Hume, Youzhi Li, Matthew Hitron, Chiang Li	5
9	Interim results of a randomized phase II study of PEGPH20 added to nab-paclitaxel/gemcitabine in patients with stage IV previously untreated pancreatic cancer. 2016 ·Journal of Clinical Oncology ·Sunil R. Hingorani, William Proctor Harris, Tara Elisabeth Seery, Lei Zheng, Darren Sigal, Andrew Hendifar, Fadi Braiteh, Mark M. Zalupski, Ari David Baron, Nathan Bahary, Andrea Wang‐Gillam, Noelle K. LoConte, Gregory M. Springett, Paul S. Ritch, Aram F. Hezel, Wen Wee, Venu Bathini, Xionghua Wu, Ping Jiang, Andrea J. Bullock	22
10	14LBA Atezolizumab monotherapy vs docetaxel in 2L/3L non-small cell lung cancer: Primary analyses for efficacy, safety and predictive biomarkers from a randomized phase II study (POPLAR) 2015 ·European Journal of Cancer ·Johan Vansteenkiste, L. Fehrenbacher, Alexander I. Spira, Julien Mazières, K. Park, (unknown), Á. Artal, C. Lewanski, Fadi Braiteh, (unknown), (unknown), Marcin Kowanetz, Daniel Waterkamp, M. Ballinger, (unknown), A. Sandler, Achim Rittmeyer	28
11	Abstract PD1-6: Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer 2015 ·Cancer Research ·Leisha A. Emens, Fadi Braiteh, Philippe A. Cassier, Jean‐Pierre Delord, Joseph P. Eder, Xiaodong Shen, Yuanyuan Xiao, Yan Wang, Priti S. Hegde, Daniel S. Chen, Ian E. Krop	25
12	Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy 2009 ·Cancer ·Fadi Braiteh, Arlene M. Correa, Wayne L. Hofstetter, David C. Rice, Ara A. Vaporciyan, Garrett L. Walsh, Jack A. Roth, Reza J. Mehran, Stephen G. Swisher, Jaffer A. Ajani	12
13	Spontaneous haemopericardium with subacute cardiac tamponade in a patient with lung cancer receiving coumadin 2009 ·QJM ·Fadi Braiteh, Juan Carlos Plana	8
14	Complete Remission of Psoriasis After Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma 2008 ·Journal of Clinical Oncology ·Fadi Braiteh, Sharon R. Hymes, Sergio Giralt, Roy B. Jones	16
15	Patients’ characteristics and outcomes of palliative care inpatient consults at a comprehensive cancer center 2006 ·Journal of Clinical Oncology ·Badi El Osta, Fadi Braiteh, Suresh Reddy, (unknown), Éduardo Bruera	1
16	Phase II clinical trial of curcumin in patients with advanced pancreatic cancer 2006 ·Journal of Clinical Oncology ·(unknown), Robert A. Wolff, James L. Abbruzzese, David S. Hong, Luis H. Camacho, (unknown), Fadi Braiteh, Razelle Kurzrock	36
17	Phase I study of the safety and efficacy of atiprimod, a novel azaspirine, for patients with advanced cancer 2006 ·Journal of Clinical Oncology ·Fadi Braiteh, James C. Yao, Luis H. Camacho, Chaan S. Ng, David S. Hong, (unknown), Navneet K. Dhillon, Razelle Kurzrock	4
18	Pain and Terminal Delirium Research in the Elderly 2005 ·Clinics in Geriatric Medicine ·Sriram Yennurajalingam, Fadi Braiteh, Éduardo Bruera	26
19	Successful treatment of Erdheim-Chester disease, a non–Langerhans-cell histiocytosis, with interferon-α 2005 ·Blood ·Fadi Braiteh, Cynthia A. Boxrud, Bita Esmaeli, Razelle Kurzrock	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact